ADMET & DMPK
ADMET & DMPK
Cilt: 4 Sayı: 4
ROCK inhibitors in ocular disease
Cilt: 4, Sayı: 4 Sayfalar 280-301 Éva Halász, Ellen Townes-Anderson ADMET & DMPK
Tyrosine and aurora kinase inhibitors diminish transport function of multidrug resistance-associated protein (MRP) 4 and breast cancer resistance protein (BCRP)
Cilt: 4, Sayı: 4 Sayfalar 302-313 Rhiannon N. Hardwick, Marina Snellings, Brian C. Ferslew, Yang Lu, Kim L.R. Brouwer ADMET & DMPK
Preclinical formulation for the pharmacokinetics and efficacy of GBO-006, a selective polo like kinase 2 (PLK2) inhibitor for the treatment of triple negative breast cancer
Cilt: 4, Sayı: 4 Sayfalar 314-326 Srinivas Maddi, Ravi Akkireddy, Srinivas Lenkalapelly, Pratima Srivastava, Joshodeep Boruwa, Chandra Deb, Arnab Roy Chowdhury, Duraiswamy A. Jeyaraj, Ramana Reddy, Premkumar Reddy, Manoj Maniar, Sachin Bansal, Jang B. Gupta ADMET & DMPK
Tissue distribution of crizotinib and gemcitabine combination in a patient-derived orthotopic mouse model of pancreatic cancer
Cilt: 4, Sayı: 4 Sayfalar 327-334 Richard J Honeywell, Amir Avan, Elisa Giovannetti, Godefridus J Peters ADMET & DMPK
Investigation of biopharmaceutical and physicochemical drug properties suitable for orally disintegrating tablets
Cilt: 4, Sayı: 4 Sayfalar 335-360 Asami Ono, Takumi Tomono, Takuo Ogihara, Katsuhide Terada, Kiyohiko Sugano ADMET & DMPK
Dergiye ait tüm sayılar